The most sustainable hospitals in the world include Kaiser Permanente, King’s College Hospital NHS Trust, Cleveland Clinic ...

AI is used for analysing imaging (e.g., brain tumours, cancer detection), screening and identifying biomarkers. Credit: Imperial College London The UK Government’s US$2.2bn AI strategy aims to boost ...

Johnson & Johnson has invested US$1bn in Pennsylvania cell therapy facility to expand cancer treatment access and reduce personalised medicine costs Johnson & Johnson's announcement on 18 February ...

"What patients eat can be as vital as the treatments they receive," writes Elevance Health. Credit: Elevance Health via LinkedIn Elevance Health advances digital, sustainable and personalised ...

Sanofi appoints Belén Garijo as first female CEO, marking leadership change amid strategic challenges and investor concerns over future growth The French pharmaceutical giant Sanofi has appointed ...

Healthcare Digital lists the Top 10 AI platforms being used in the healthcare sector aiming to deliver high-quality care and improve patient outcomes AI platforms are emerging as essential tools in ...

DXC’s Customer Experience Centre shows how organisations can turn AI strategy into enterprise‑scale outcomes through collaboration and co‑creation DXC Technology has launched a new London Customer ...

McKinsey’s 2026 outlook reveals how artificial intelligence is transforming US healthcare delivery and operational efficiency McKinsey released its "What to expect in US healthcare in 2026 and beyond" ...

P&G's Chief Sustainability Officer Virginie Helias ranks sixth in Top 250 Leaders, driving healthcare innovation and impact across global operations The recognition highlights her dedication to ...

dsm-firmenich sells Animal Nutrition & Health business to CVC for €2.2bn (US$2.6bn) to sharpen its focus on nutrition, health and beauty sectors In a move that could sharpen its strategic focus on ...

Under new CEO Luke Miels, GSK posts its full-year results, highlighting Specialty Medicines growth and a deliberately modest 2026 outlook GSK has unveiled its fourth-quarter and full-year 2025 results ...